Medtronic Cash on Hand 2010-2025 | MDT
Medtronic cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Medtronic cash on hand for the quarter ending January 31, 2025 was $7.922B, a 4.8% decline year-over-year.
- Medtronic cash on hand for 2024 was $8.005B, a 0.58% increase from 2023.
- Medtronic cash on hand for 2023 was $7.959B, a 24.72% decline from 2022.
- Medtronic cash on hand for 2022 was $10.573B, a 2.26% decline from 2021.
| Medtronic Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $8,005 |
| 2023 | $7,959 |
| 2022 | $10,573 |
| 2021 | $10,817 |
| 2020 | $10,948 |
| 2019 | $9,848 |
| 2018 | $11,227 |
| 2017 | $13,708 |
| 2016 | $12,634 |
| 2015 | $19,480 |
| 2014 | $14,241 |
| 2013 | $11,130 |
| 2012 | $9,350 |
| 2011 | $2,428 |
| 2010 | $3,775 |
| 2009 | $1,676 |
| Medtronic Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-01-31 | $7,922 |
| 2024-10-31 | $7,989 |
| 2024-07-31 | $7,843 |
| 2024-04-30 | $8,005 |
| 2024-01-31 | $8,321 |
| 2023-10-31 | $7,734 |
| 2023-07-31 | $7,876 |
| 2023-04-30 | $7,959 |
| 2023-01-31 | $11,137 |
| 2022-10-31 | $11,430 |
| 2022-07-31 | $8,873 |
| 2022-04-30 | $10,573 |
| 2022-01-31 | $11,221 |
| 2021-10-31 | $10,669 |
| 2021-07-31 | $10,595 |
| 2021-04-30 | $10,817 |
| 2021-01-31 | $14,639 |
| 2020-10-31 | $14,277 |
| 2020-07-31 | $13,012 |
| 2020-04-30 | $10,948 |
| 2020-01-31 | $11,628 |
| 2019-10-31 | $10,398 |
| 2019-07-31 | $10,683 |
| 2019-04-30 | $9,848 |
| 2019-01-31 | $9,142 |
| 2018-10-31 | $10,133 |
| 2018-07-31 | $11,004 |
| 2018-04-30 | $11,227 |
| 2018-01-31 | $14,436 |
| 2017-10-31 | $13,526 |
| 2017-07-31 | $13,088 |
| 2017-04-30 | $13,708 |
| 2017-01-31 | $11,458 |
| 2016-10-31 | $11,257 |
| 2016-07-31 | $12,810 |
| 2016-04-30 | $12,634 |
| 2016-01-31 | $17,286 |
| 2015-10-31 | $17,229 |
| 2015-07-31 | $17,982 |
| 2015-04-30 | $19,480 |
| 2015-01-31 | $31,148 |
| 2014-10-31 | $14,464 |
| 2014-07-31 | $13,962 |
| 2014-04-30 | $14,241 |
| 2014-01-31 | $13,667 |
| 2013-10-31 | $12,584 |
| 2013-07-31 | $11,404 |
| 2013-04-30 | $11,130 |
| 2013-01-31 | $2,464 |
| 2012-10-31 | $2,675 |
| 2012-07-31 | $2,491 |
| 2012-04-30 | $9,350 |
| 2012-01-31 | $2,345 |
| 2011-10-31 | $2,166 |
| 2011-07-31 | $2,521 |
| 2011-04-30 | $2,428 |
| 2011-01-31 | $3,467 |
| 2010-10-31 | $3,544 |
| 2010-07-31 | $3,917 |
| 2010-04-30 | $3,775 |
| 2010-01-31 | $2,292 |
| 2009-10-31 | $1,542 |
| 2009-07-31 | $1,544 |
| 2009-04-30 | $1,676 |
| 2009-01-31 | $1,743 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $115.624B | $32.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $234.047B | 28.90 |
| Boston Scientific (BSX) | United States | $154.056B | 41.59 |
| Stryker (SYK) | United States | $148.022B | 31.82 |
| EssilorLuxottica (ESLOY) | France | $137.298B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.792B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.950B | 29.85 |
| GE HealthCare Technologies (GEHC) | United States | $41.418B | 20.17 |
| Agilent Technologies (A) | United States | $38.594B | 25.57 |
| ResMed (RMD) | United States | $33.728B | 25.98 |
| Terumo (TRUMY) | Japan | $25.984B | 36.95 |
| Koninklijke Philips (PHG) | Netherlands | $24.420B | 17.44 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.098B | 13.25 |
| Insulet (PODD) | United States | $19.908B | 85.13 |
| Baxter (BAX) | United States | $17.948B | 12.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.490B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.348B | 35.03 |
| Demant (WILYY) | Denmark | $8.092B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.847B | 27.17 |
| Lantheus Holdings (LNTH) | United States | $5.489B | 12.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.215B | 20.11 |
| ICU Medical (ICUI) | United States | $3.924B | 37.35 |
| Envista Holdings (NVST) | United States | $3.683B | 29.30 |
| Perrigo (PRGO) | Ireland | $3.443B | 10.14 |
| Haemonetics (HAE) | United States | $3.312B | 15.58 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.850B | 19.20 |
| QuidelOrtho (QDEL) | United States | $2.822B | 23.71 |
| LeMaitre Vascular (LMAT) | United States | $2.294B | 55.75 |
| Neogen (NEOG) | United States | $2.261B | 26.05 |
| AtriCure (ATRC) | United States | $1.916B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.494B | 26.06 |
| InMode (INMD) | Israel | $1.330B | 11.12 |
| BioLife Solutions (BLFS) | United States | $1.193B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.150B | 8.22 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.013B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.920B | 0.00 |
| CeriBell (CBLL) | United States | $0.911B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.896B | 13.74 |
| Evolus (EOLS) | United States | $0.893B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.657B | 0.00 |
| Valneva SE (VALN) | France | $0.635B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.538B | 23.32 |
| Omeros (OMER) | United States | $0.503B | 0.00 |
| Surmodics (SRDX) | United States | $0.501B | 0.00 |
| Owens & Minor (OMI) | United States | $0.493B | 3.85 |
| SNDL (SNDL) | Canada | $0.439B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.432B | 0.00 |
| ZimVie (ZIMV) | United States | $0.368B | 30.98 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.349B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.349B | 0.00 |
| Quanterix (QTRX) | United States | $0.311B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.308B | 56.10 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.300B | 28.52 |
| OraSure Technologies (OSUR) | United States | $0.298B | 19.95 |
| Biote (BTMD) | United States | $0.252B | 5.52 |
| Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
| Zynex (ZYXI) | United States | $0.234B | 49.07 |
| Sanuwave Health (SNWV) | United States | $0.231B | 3.24 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.204B | 15.21 |
| Brainsway (BWAY) | Israel | $0.184B | 97.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| MacroGenics (MGNX) | United States | $0.166B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.164B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 17.17 |
| Jin Medical (ZJYL) | China | $0.114B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 12.92 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Veru (VERU) | United States | $0.083B | 0.00 |
| InterCure (INCR) | Israel | $0.076B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.069B | 0.00 |
| Exagen (XGN) | United States | $0.063B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.060B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.057B | 29.17 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| Hongchang (HCIL) | China | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.046B | 13.24 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| INLIF (INLF) | $0.032B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.009B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |